Intermediate cardiovascular risk
Showing 1 - 25 of >10,000
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Active, not recruiting
- Cardiovascular Diseases
- +3 more
- Soy milk
-
Toronto, Ontario, CanadaClinical Nutrition and Risk Factor Modification Centre, St. Mich
Nov 28, 2022
Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary Trial in Tehran (Conventional catheter-directed thrombolysis
Terminated
- Pulmonary Embolism
- +3 more
- Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA)
- Enoxaparin
-
Tehran, Iran, Islamic Republic ofRajaie Cardiovascular Medical and Research Center
Dec 28, 2021
Intermediate to High-risk Asymptomatic Sportsmen With Exercise
Completed
- Electrocardiography
- Screening stress test on a bicycle ergometer (usual practise)
-
Saint-Étienne, FranceCentre Hospitalier de Saint-Etienne
Sep 6, 2023
Aortic Valve Stenosis Trial in United States (TAVR with CENTERA THV)
Active, not recruiting
- Aortic Valve Stenosis
- TAVR with CENTERA THV
-
Los Angeles, California
- +22 more
Oct 7, 2022
Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)
Recruiting
- Pulmonary Embolism
- ultrasound-assisted, catheter-directed thrombolysis
-
Milano, Italia, ItalyASST GOM Niguarda
Nov 21, 2023
All Conditions Requiring Non-cardiac Surgery Trial (Training)
Not yet recruiting
- All Conditions Requiring Non-cardiac Surgery
- Training
- (no location specified)
Oct 30, 2023
Long Term Cardiovascular Disease Event Risk for Patients
Not yet recruiting
- Cardiovascular Diseases
- Risk Reduction Behavior
- Healthy lifestyle behaviors around the time of surgery
- (no location specified)
Feb 8, 2023
Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -
Not yet recruiting
- Anal Squamous Cell Carcinoma
- Radiotherapy - Low risk group
- +3 more
- (no location specified)
Sep 18, 2023
Chest Pain, Acute Coronary Syndrome, Coronary Artery Disease Trial in Stockholm (Coronary computed tomopraphic angiography)
Recruiting
- Chest Pain
- +2 more
- Coronary computed tomopraphic angiography
-
Stockholm, SwedenDanderyd Hospital
Aug 16, 2022
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)
Recruiting
- Prostate Cancer
- [18F]Florastamin Injection
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 21, 2023
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
Cardiovascular Diseases Trial (Cardiovascular disease risk assessment, Training and Consultancy, Mobile Application)
Not yet recruiting
- Cardiovascular Diseases
- Cardiovascular disease risk assessment
- +3 more
- (no location specified)
Aug 16, 2023
Pulmonary Embolism Subacute Massive Trial (Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction
Not yet recruiting
- Pulmonary Embolism Subacute Massive
- Mechanical embolectomy: by hydromechanical defragmentation by pigtail
- Suction embolectomy by the Penumbra Indigo aspiration system
- (no location specified)
Nov 9, 2022
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Screening CEDM in Intermediate and High-Risk Patient Populations
Completed
- Breast Cancer
- Contrast Enhanced Digital Mammography
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 18, 2023
Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)
Not yet recruiting
- Prostatic Cancer
- High Dose Brachytherapy
- Stereostatic Body Radiation Therapy
- (no location specified)
Mar 3, 2023
Cardiovascular Disease, Alcohol Use Disorder, HIV Risk Trial in New York (Navigation, compensation, and personalization)
Not yet recruiting
- Cardiovascular Disease
- +3 more
- Navigation, compensation, and personalization
-
New York, New YorkNYC H+H/Bellevue
Apr 13, 2023
Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)
Not yet recruiting
- Prostate Cancer
- Relugolix 120 MG [Orgovyx]
- SBRT standard of care radiotherapy treatment
-
New Haven, ConnecticutYale Cancer Center
Oct 26, 2023
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
Pulmonary Embolism Trial in Prague (Thrombolytic, Standard anticoagulation)
Not yet recruiting
- Pulmonary Embolism
- Thrombolytic
- Standard anticoagulation
-
Prague, CzechiaUniversity Hospital Kralovske Vinohrady
Aug 5, 2022